Skip to main content

COVAXIN: Do you know about India's first indigenous vaccine for COVID-19?

India's first indigenous vaccine for COVID-19: In a piece of good news, India's first coronavirus vaccine-- COVAXIN-- developed by Hyderabad-based Bharat Biotech has got green signal from the Drug Controller General of India (DCGI) to conduct human clinical trials.

Amid the surging COVID-19 cases around the world, in a piece of good news, India's first coronavirus vaccine-- COVAXIN-- developed by Hyderabad-based Bharat Biotech has got green signal from the Drug Controller General of India (DCGI) to start with human clinical trials. 
The vaccine is made in collaboration with ICMR (Indian Council of Medical Research) and NIV (National Institute of Virology). 
The SARS-CoV-2 strain was isolated in NIV, Pune and was transferred to Bharat Biotech. The inactivated COVID-19 vaccine, developed at Bharat Biotech’s BSL-3 (Bio-Safety Level 3) high containment facility located in the Genome Valley, Hyderabad, has got approval to begin its Phase I and Phase II human clinical trials. 
The permission was granted by The DGCI, CDSCO (Central Drugs Standard Control Organisation), and Ministry of Health and Family Welfare after the company submitted the results of pre-clinical studies related to safety and immune response.  
These clinical trials are designed to test whether the vaccines are safe or not. The effectiveness of the vaccine will be tested in the next phases. Volunteers across India will be immunised with 'Made in India' COVID-19 vaccine in July 2020. However, the number of people and the date has not been mentioned yet. 
Prime Minister Modi in 'Man ki Baat' stated that work is being done in the labs on Coronavirus vaccine and the world is keenly observing India and the country is hopeful too. 
Bharat Biotech's Chairman and MD, Dr Krishna Ella stated that the company is proud to announce COVAXIN, India's first indigenous vaccine against COVID-19. The collaboration with ICMR and NIV was instrumental in the development of this vaccine. The company's Research and Development and  Manufacturing teams have worked tirelessly to deploy the proprietary technologies towards this platform. 
Bharat Biotech has a good track record when it comes to developing Vero cell culture platform technologies and has given successful vaccines for Polio, Rabies, Rotavirus, Japanese Encephalitis, Chikungunya and Zika. 
Apart from this, 5 other Indian firms are working on COVID-19 vaccine. Around 120 vaccine programs in the world are underway. Pharma companies, researchers and scientists around the globe are working day and night to develop COVID-19 vaccine.  

Comments

Post a Comment

Popular posts from this blog

GK Questions and Answers: Geographical Indications (GI) Tags in India

A geographical indication (GI) is a name or sign used on certain products like agriculture, machinery products, and sweets, etc. which relates to a specific geographical location or origin (e.g., region, or country or a town). We have published a set of 10 important GK questions and answers on the Geographical Indications (GI) Tags in India. This set of 10 important GK questions and answers on the Geographical Indications (GI) Tags in India is very important for exams like UPSC/PSC/SSC/CDS etc. 1. Which was the first Indian product to get the geographical indication tag? (a).Aranmula Kannadi (b).Darjeeling Tea (c).Katarni Rice (d).Madhubani Paintings Answer:- b Explanation:-  Darjeeling Tea was the first Indian product to get the geographical indication tag in 2004.  2. How many products got GI tags till now? (a) 361 (b) 729 (c) 624 (d) None of the above Answer:- a Explanation:-  Till date 361 products have been issued GI tag. The latest recipient of the GI ta...
Post a Comment
Read more

NDA Previous Year Cut Off Marks

Here is the previous year cutoff marks of   NDA exam , as well as subject-wise NDA cut off for the years 2019, 2018, 2017, 2016, 2015, 2014, 2013 and 2014 in this post. So, if you are appearing or preparing for UPSC NDA & NA examination, then get an idea about the minimum marks from below. Paper Written Exam Final Exam NDA & NA (II) 2019 346 709 NDA & NA (I) 2019 342 704 NDA & NA (II) 2018 325 688 NDA & NA (I) 2018 338 705 NDA & NA (II) 2017 258 624 NDA & NA (I) 2017 342 708 NDA & NA (II) 2016 229 602 NDA & NA (I) 2016 288 656 NDA & NA (II) 2015 269 637 NDA & NA (I) 2015 306 674 NDA & NA (II) 2014 283 656 NDA & NA (I) 2014 360 722 NDA & NA (II) 2013 360 721 NDA & NA (I) 2013 333 698 NDA & NA (II) 2012 335 699 Sectional UPSC Cut Off for NDA & NA There are also variations in the sectional cut off marks in NDA. Usually, it's around 25% to 30% somewhere. Check the UPSC NDA & NA sectional cut off from below the prev...
Post a Comment
Read more

What is sero-surveillance? How will it help in tracking COVID-19 infection?

Sero-surveillance: The Indian Council of Medical Research, ICMR has issued an advisory to all the states of India to conduct serosurvey to monitor the Coronavirus pandemic. The Indian Council of Medical Research, ICMR has issued an advisory to all the states of India to conduct serosurvey to monitor the Coronavirus pandemic. The advisory further states that these tests can be carried out on frontline workers, medical professionals, vendors, police personnel, the staff of restaurants and grocery shops, etc. In addition to these, individuals residing in the containment zones and patients with chronic illness tuberculosis, HIV, etc. will also be covered.  The survey will also be conducted on asymptomatic individuals and the previously infected COVID-19 hit patients that have now recovered. The survey will be conducted with the help of the ELISA test kit.  What is sero-surveillance? In serosurvey or sero-surveillance, testing of blood serum of a group of individuals is c...
Post a Comment
Read more